Dr. Scher on Key Findings From the COU-AA-302 Trial
May 13th 2013Howard I. Scher, MD, from the Memorial Sloan-Kettering Cancer Center, discusses an updated analysis of the COU-AA-302 trial, which examined treatment with abiraterone in men with mCRPC prior to the administration of chemotherapy.
Read More